Profilo
Jacques Corriveau is currently the Chief Executive Officer at Codetta Bio, Inc. He previously worked as the President & Chief Executive Officer at Ultivue, Inc.
Posizioni attive di Jacques Corriveau
| Società | Posizione | Inizio |
|---|---|---|
Codetta Bio, Inc.
 Codetta Bio, Inc. BiotechnologyHealth Technology Codetta Bio, Inc. is a company that researches and develops a quantitative and digital spatial platform for nucleic acid and protein assays. The company is based in Morrisville, NC. The CEO of the company is Anthony V. Lemmo. | Amministratore Delegato | 11/10/2023 |
Precedenti posizioni note di Jacques Corriveau
| Società | Posizione | Fine |
|---|---|---|
Ultivue, Inc.
 Ultivue, Inc. BiotechnologyHealth Technology Ultivue, Inc. engages in provision of biotechnology services. It offers super-resolution imaging, single-molecule and diagnostics services. Its product Multiplex IHC Reagent Kits, a performance marker multiplexing detection and analysis.The company was founded by Peng Yin, David Walt and Ralf Jumgmann in 2015 and is headquartered in Cambridge, MA. | Amministratore Delegato | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Ultivue, Inc.
Ultivue, Inc. BiotechnologyHealth Technology Ultivue, Inc. engages in provision of biotechnology services. It offers super-resolution imaging, single-molecule and diagnostics services. Its product Multiplex IHC Reagent Kits, a performance marker multiplexing detection and analysis.The company was founded by Peng Yin, David Walt and Ralf Jumgmann in 2015 and is headquartered in Cambridge, MA. | Health Technology |
Codetta Bio, Inc.
Codetta Bio, Inc. BiotechnologyHealth Technology Codetta Bio, Inc. is a company that researches and develops a quantitative and digital spatial platform for nucleic acid and protein assays. The company is based in Morrisville, NC. The CEO of the company is Anthony V. Lemmo. | Health Technology |
- Borsa valori
- Insiders
- Jacques Corriveau
